superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2022-09-30
- Valid until
- 2023-03-31
- Published
- 2022-11-01
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 1,985,100,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Eli Lilly and Company quarterly research and development: 1,802,900,000 United States dollar", as of 2022-09-30 (until 2023-03-31). Claim clm_DB412511FD99, https://asof.is/claim/clm_DB412511FD99, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/59478/000005947822000250/0000059478-22-000250-index.htm.
APA
AsOf. (2022). Eli Lilly and Company quarterly research and development: 1,802,900,000 United States dollar (as of 2022-09-30 (until 2023-03-31)) [Record clm_DB412511FD99]. Retrieved November 9, 2026, from https://asof.is/claim/clm_DB412511FD99 (source: https://www.sec.gov/Archives/edgar/data/59478/000005947822000250/0000059478-22-000250-index.htm)
BibTeX
@misc{asof_clm_DB412511FD99,
author = {AsOf},
title = {Eli Lilly and Company quarterly research and development: 1,802,900,000 United States dollar},
year = {2022},
howpublished = {\url{https://asof.is/claim/clm_DB412511FD99}},
note = {Claim clm\_DB412511FD99, as of 2022-09-30 (until 2023-03-31); source: https://www.sec.gov/Archives/edgar/data/59478/000005947822000250/0000059478-22-000250-index.htm},
urldate = {2026-11-09}
}Supersedes
On the record
/claim/clm_DB412511FD99.md/v1/claims/clm_DB412511FD99submit a correction